Mainstream

Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

Zevra Therapeutics GAAP EPS of -$0.06 beats by $0.13, revenue of $20.4M beats by $3.44M

Post ContentzvraRead More

You might also be interested in reading DeFi Money Market closure after SEC probe could set rocky precedent.

May 14, 2025
In Mainstream